| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.1 | 0.4 |